EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway

Punnida Arjsri iD, Kamonwan Srisawad iD, Sonthaya Umsumarng iD, Pilaiporn Thippraphan, Songyot Anuchapreeda iD, Pornngarm Dejkriengkraikul iD

Biomolecules · 10.01.2025 · 15 (1) · 103

DOI: 10.3390/biom15010103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.01.2025. Verfasst von Punnida Arjsri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Carcinoma, Non-Small-Cell Lung, Flavonoids, Lung Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Fund from the National Research of Thailand (NRCT) and Chiang Mail Uni-versity, Fundamental Fund from the National Research of Thailand (NRCT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths globally, with a persistently low five-year survival rate of only 14–17%. High rates of metastasis contribute significantly to the poor prognosis of NSCLC, in which inflammation plays an important role by enhancing tumor growth, angiogenesis, and metastasis. Targeting inflammatory pathways within cancer cells may thus represent a promising strategy for inhibiting NSCLC metastasis. This study evaluated the anti-inflammatory and anti-metastatic properties of morin, a bioactive compound derived from a Thai medicinal herb, focusing on its effects on NLRP3 inflammasome-mediated pathways in an in vitro NSCLC model. The A549 and H1299 cell lines were stimulated with lipopolysaccharide (LPS) and adenosine triphosphate (ATP) to activate the NLRP3 pathway. The inhibition effects exhibited by morin in reducing pro-inflammatory secretion in LPS- and ATP-stimulated NSCLC cells were assessed by ELISA, while wound healing and trans-well invasion assays evaluated its impact on cell migration and invasion. RT-qPCR measurement quantified the expression of inflammatory genes, and zymography and Western blotting were used to examine changes in invasive protein levels, epithelial-to-mesenchymal transition (EMT) markers, and underlying molecular mechanisms. Our findings demonstrated the significant ability of morin to decrease the production of IL-1β, IL-18, and IL-6 in a dose-dependent manner (p < 0.05), as well as suppress NSCLC cell migration and invasion. Morin downregulated invasive proteins (MMP-2, MMP-9, u-PAR, u-PA, MT1-MMP) and EMT markers (fibronectin, N-cadherin, vimentin) (p < 0.01) while also reducing the mRNA levels of NLRP3, IL-1β, IL-18, and IL-6. Mechanistic investigations revealed that morin suppressed NLRP3 inflammasome activity and inactivated MAPK pathways. Specifically, it decreased the expression of NLRP3 and ASC proteins and reduced caspase-1 activity, while reducing the phosphorylation of ERK, JNK, and p38 proteins. Collectively, these findings suggest that morin’s inactivation of the NLRP3 inflammasome pathway could offer a novel therapeutic strategy for counteracting pro-tumorigenic inflammation and metastatic progression in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCarcinoma, Non-Small-Cell LungFlavonoidsLung NeoplasmsAnti-Inflammatory AgentsMAP Kinase Signaling SystemHumansCell MovementCell Line, TumorLipopolysaccharidesInflammasomesNeoplasm MetastasisEpithelial-Mesenchymal TransitionA549 CellsFlavones

Stichwörter der Autor:innen

NLRP3 inflammasome pathwayinflammationmetastasismorinnon-small-cell lung cancer

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinFlavonoidsmorinNLRP3 protein, humanAnti-Inflammatory AgentsLipopolysaccharidesInflammasomesFlavones

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.
  • Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Punnida Arjsri, Kamonwan Srisawad, Sonthaya Umsumarng, Songyot Anuchapreeda, Pornngarm Dejkriengkraikul

Förderung

  • the Fundamental Fund from the National Research of Thailand (NRCT) and Chiang Mail Uni-versity
  • Fundamental Fund from the National Research of Thailand (NRCT)

Zitieren

APA

Arjsri, P., Srisawad, K., Umsumarng, S., Thippraphan, P., Anuchapreeda, S., & Dejkriengkraikul, P. (2025). Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway. Biomolecules, 15(1), 103. https://doi.org/10.3390/biom15010103

Vancouver

Arjsri P, Srisawad K, Umsumarng S, Thippraphan P, Anuchapreeda S, Dejkriengkraikul P. Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway. Biomolecules. 2025;15(1):103. doi:10.3390/biom15010103

BibTeX
@article{Arjsri2025,
  author = {Arjsri, Punnida and Srisawad, Kamonwan and Umsumarng, Sonthaya and Thippraphan, Pilaiporn and Anuchapreeda, Songyot and Dejkriengkraikul, Pornngarm},
  title = {Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {103},
  doi = {10.3390/biom15010103}
}
Kostenlos starten →